Imc Chicago, LLC Biomarin Pharmaceutical Inc Transaction History

Imc Chicago, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 19, 2022	SELL	$74.28 - $92.69 $1.31 Million - $1.63 Million	-17,576 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$71.72 - $91.47 $1.26 Million - $1.61 Million	17,576 New	17,576 $1.55 Million
Q2 2021 Aug 06, 2021	SELL	$75.51 - $84.79 $1.82 Million - $2.05 Million	-24,121 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$74.73 - $90.69 $1.8 Million - $2.19 Million	24,121 New	24,121 $1.82 Million
Q1 2019 May 15, 2019	SELL	$84.2 - $98.62 $243,506 - $285,209	-2,892 Closed	0 $0
Q4 2018 Apr 24, 2019	BUY	$80.14 - $106.07 $231,764 - $306,754	2,892 New	2,892 $246,000

637

177M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Imc Chicago, LLC, based on Form 13F filings with the SEC.

Stay updated on Imc Chicago, LLC with notifications on news.